C. Couchoud, B. Stengel, P. Landais, J. Aldigier, F. De-comelissen et al., The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrology Dialysis Transplantation, vol.21, issue.2, pp.411-419, 2006.
DOI : 10.1093/ndt/gfi198

URL : https://hal.archives-ouvertes.fr/hal-00452918

D. Nicola, L. Minutolo, R. Chiodini, and P. , Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention, Kidney International, vol.69, issue.3, pp.538-583, 2006.
DOI : 10.1038/sj.ki.5000085

L. Abenhaim, L. Gales, and C. , Direction générale de la Santé Élaboration de la loi relative à la politique de santé publique Rapport du Groupe Technique National de Définition des Objectifs (analyse des connaissances disponibles sur des problèmes de santé sélectionnés, leurs déterminants et les stratégies de santé publique) Paris: ministère de la santé, 2003.

A. Nationale-d, Accréditation et d'Evaluation en Santé. Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte, 2004.

E. Schmitt, D. Antier, C. Bernheim, E. Dufay, M. Husson et al., Dictionnaire français de l'erreur médicamenteuse, p.64, 2006.

P. Michel, J. Quenon, A. Djihoud, S. Tricaud-vialle, A. De-sarasqueta et al., Les événements indésirables graves liés aux soins observés dans les établissements de santé : premiers résultats d'une étude nationale (Enquête ENEIS), DRESS Etudes et Résultats, vol.398, pp.1-16, 2005.

Y. Lam, S. Banerji, C. Hatfield, and R. Talbert, Principles of Drug Administration in Renal Insufficiency, Clinical Pharmacokinetics, vol.32, issue.1, pp.30-57, 1997.
DOI : 10.2165/00003088-199732010-00002

G. Matzke and R. Frye, Drug Administration in Patients with Renal Insufficiency Minimising Renal and Extrarenal Toxicity, Drug Safety, vol.16, issue.3, pp.205-236, 1997.
DOI : 10.2165/00002018-199716030-00005

J. Borenstein, G. Graber, and E. Saltiel, Physician-Pharmacist Comanagement of Hypertension: A Randomized, Comparative Trial, Pharmacotherapy, vol.58, issue.18, pp.209-225, 2003.
DOI : 10.1331/108658002763316824

D. Solomon, T. Portner, and G. Bass, Part 2. Clinical and Economic Outcomes in the Hypertension and COPD Arms of a Multicenter Outcomes Study, Journal of the American Pharmaceutical Association (1996), vol.38, issue.5, pp.574-85, 1998.
DOI : 10.1016/S1086-5802(16)30371-0

L. Jaber, H. Halapy, M. Femet, S. Tummalapalli, and H. Diwakaran, Evaluation of a Pharmaceutical Care Model on Diabetes Management, Annals of Pharmacotherapy, vol.48, issue.3, pp.238-281, 1996.
DOI : 10.1056/NEJM199309303291401

E. Coast-senior, B. Kroner, C. Kelley, and L. Trilli, Management of Patients with Type 2 Diabetes by Pharmacists in Primary Care Clinics, Annals of Pharmacotherapy, vol.78, issue.1, pp.636-677, 1998.
DOI : 10.1056/NEJM199309303291401

P. Huff, T. Ives, S. Almond, and N. Griffin, Pharmacist-managed diabetes education service, Am J Hosp Pharm, vol.40, pp.991-995, 1983.

K. Schilling, Pharmacy program for monitoring diabetic patients, Am J Hosp Pharm, vol.34, pp.1242-1247, 1977.

J. Tiggelaar, Protocols for the treatment of essential hypertension and type II diabetes mellitus by pharmacists in ambulatory care clinics. Drug Intell Clin Pham1, pp.521-530, 1987.

C. Sadur, N. Moline, and M. Costa, Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits, Diabetes Care, vol.22, issue.12, pp.2011-2018, 1999.
DOI : 10.2337/diacare.22.12.2011

M. Shibley and C. Pugh, Implementation of Pharmaceutical Care Services for Patients with Hyperlipidemias by Independent Community Pharmacy Practitioners, Annals of Pharmacotherapy, vol.21, issue.3, pp.713-722, 1997.
DOI : 10.1177/106002809703100608

R. Tsuyuki, J. Johnson, and K. Teo, A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management<subtitle>The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</subtitle>, Archives of Internal Medicine, vol.162, issue.10, pp.1149-55, 2002.
DOI : 10.1001/archinte.162.10.1149

S. Ellis, B. Carter, and D. Malone, Clinical and Economic Impact of Ambulatory Care Clinical Pharmacists in Management of Dyslipidemia in Older Adults: The IMPROVE Study, Pharmacotherapy, vol.12, issue.12, pp.1508-1524, 2000.
DOI : 10.1001/archinte.155.21.2330

M. Bozovich, C. Rubino, and J. Edmunds, Effect of a Clinical Pharmacist-Managed Lipid Clinic on Achieving National Cholesterol Education Program Low-Density Lipoprotein Goals, Pharmacotherapy, vol.98, issue.9, pp.1375-83, 2000.
DOI : 10.1056/NEJM199610033351401

C. Gilmartin, Pharmacist's role in managing anemia in patients with chronic kidney disease: Potential clinical and economic benefits, American Journal of Health-System Pharmacy, vol.64, issue.13 Supplement 8, pp.15-22, 2007.
DOI : 10.2146/ajhp070183

M. Joy, C. Candiani, B. Vaillancourt, H. Chin, S. Hogan et al., Reengineering Clinical Operations in a Medical Practice to Optimize the Management of Anemia of Chronic Kidney Disease, Pharmacotherapy, vol.42, issue.5, pp.734-778, 2007.
DOI : 10.1097/01.ASN.0000070149.78399.CE

T. Dowling, Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: An overview, American Journal of Health-System Pharmacy, vol.64, issue.13 Supplement 8
DOI : 10.2146/ajhp070181

V. Skoutakis, S. Acchiardo, D. Martinez, D. Lorisch, and G. Wood, Role-effectiveness of the pharmacist in the treatment ofhemodialysis patients, Am J Hosp Pharm, vol.35, pp.62-67, 1978.

H. Manley and C. Carroll, The Clinical and Economic Impact of Pharmaceutical Care in End-Stage Renal Disease Patients, Seminars in Dialysis, vol.157, issue.1, pp.45-54, 2002.
DOI : 10.1046/j.1525-139x.2002.00014.x

E. Brudieu, P. Bedouch, B. Allenet, J. Calop, L. Chavanel et al., Place de l'informatisation du circuit du médicament dans la stratégie de lutte contre l'iatrogénie médicamenteuse, pp.mars-avril, 2005.

P. Bedouch, B. Allenet, and J. Labarere, Diffusion des opinions pharmaceutiques dans le cadre d???une activit?? de pharmacie clinique en unit?? de soins, Th??rapie, vol.60, issue.5, pp.515-537, 2005.
DOI : 10.2515/therapie:2005015

A. Tessier, P. Bedouch, and B. Allenet, Activité de pharmacie clinique dans les unités de soins :Évaluation de l'acceptation des interventions pharmaceutiques par les prescripteurs. In: 12ème congrès de la Société Française de Pharmacie Clinique, 2006.

M. Moreigne, Quelle faisabilité de la systématisation des observations pharmaceutiques en service clinique ? Expérimentation en service de cardiologie du CHU de Grenoble, Thèse de doctorat en Pharmacie, pp.14-2007

M. Baudrant, Nouvelle approche du processus d'éducation thérapeutique centre sur l'activité du patient: creation d'un outil d'ingénierie de formation construit à partir de l'analyse de l'activité de patients diabétiques de type II, Thèse de doctorat en pharmacie, 2005.

N. Calop, Analyse des besoins des patients en termes d'éducation thérapeutique et réponses apportées à ces demandes par le professionnel de santé: application au pharmacien d'officine. Doctorat d'Etat en Sciences de !'Education, 2004.

J. Roos, B. Allenet, P. Gaudin, and J. Calop, Education thérapeutique des patients atteints de polyarthrite rhumatoïde: description du programme MédiPR, J Pharm Clin, vol.24, pp.217-240, 2005.

S. Leger, B. Allenet, J. Calop, and J. Bosson, ??ducation th??rapeutique des patients sous anticoagulants oraux pour maladie thromboembolique veineuse : description du programme Educ???AVK, Journal des Maladies Vasculaires, vol.29, issue.3, pp.145-51, 2004.
DOI : 10.1016/S0398-0499(04)96736-4

B. Allenet, C. Chen, T. Romanet, and P. Vialtel, Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency, Pharmacy World & Science, vol.20, issue.3, pp.7-11, 2007.
DOI : 10.1007/s11096-005-4800-4

M. Baudrant, B. Allenet, L. Tallec, C. Grangeat, M. Calop et al., Educating diabetic children: integrating representations by children aged 7 to 11 and their parents, Pharmacy World & Science, vol.51, issue.3, pp.699-703, 2007.
DOI : 10.1007/s11096-007-9117-z

C. Maillot, F. Gimenez, M. Brazier, J. Calop, T. Dine et al., Concept des « soins pharmaceutiques » : une approche systématique du suivi du patient Association nationale des enseignants de pharmacie clinique. Pharmacie clinique et thérapeutique, Masson. Paris, pp.21-28, 2002.

M. Fillipi, L. Mallet, B. Allenet, and J. Calop, Le processus de soins hospitalier de soins pharmaceutiques au Québec : illustration à partir d'un cas clinique, J Phann Clin, vol.22, pp.88-93, 2003.

G. Matzke, S. Peter, W. Comstock, T. Foote, and E. , Nephrology Pharmaceutical Care Preceptorship: A Programmatic and Clinical Outcomes Assessment, Annals of Pharmacotherapy, vol.55, issue.24, pp.593-602, 2000.
DOI : 10.1345/aph.19245

G. Matzke, ASHP clinical pharmacy dialysis traineeship, Nephrology Pharmacists in the« 90s Symposium, 49th Annual Meeting of the American Society of Hospital Pharmacists, 1992.

C. Halstenson, Clinical Education and Postgraduate Training Opportunities in Nephrology Pharmacy, Journal of Pharmacy Practice, vol.18, issue.3, pp.113-120, 1993.
DOI : 10.1177/089719009300600304

N. Masson, S. Peter, W. Johnson, C. Baîlie, and G. , Trainees' activities and experiences after a clinical pharmacy dialysis traineeship, Am J Health Syst Pharm, vol.56, pp.1623-1659, 1999.

A. Zillich, J. Saseen, and R. Dehart, Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy, Pharmacotherapy, vol.58, issue.8, pp.123-166, 2005.
DOI : 10.1046/j.1365-2125.2000.00247.x

M. Joy and G. Matzke, Nephrology Pharmacy: Historical Reflections and Future Challenges, Annals of Pharmacotherapy, vol.41, issue.11, pp.1884-1890, 2007.
DOI : 10.1345/aph.1K402

T. Dupin-spriet and P. Wierre, La prise en charge m??dico-pharmaceutique : l???exp??rience australienne peut-elle ??tre transpos??e en France ?, Th??rapie, vol.59, issue.4, pp.445-50, 2004.
DOI : 10.2515/therapie:2004076

. Ham, R. Moud, A. Schwartz, and M. Campbell, Collaborative drug therapy management by pharmacists-2003, Pharmacotherapy, vol.23, pp.1210-1235, 2003.

K. Lapane and C. Hughes, Pharmacotherapy Interventions Undertaken by Pharmacists in the Fleetwood Phase III Study: the Role of Process Control, Annals of Pharmacotherapy, vol.21, issue.9, pp.1522-1528, 2006.
DOI : 10.1345/aph.1G702

J. George, D. Mccaig, C. Bond, I. Cunningham, H. Diack et al., Supplementary Prescribing: Early Experiences of Pharmacists in Great Britain, Annals of Pharmacotherapy, vol.40, issue.10, pp.1843-50, 2006.
DOI : 10.1345/aph.1H227

J. Lee, K. Grace, and A. Taylor, Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol, JAMA, vol.296, issue.21, pp.2563-71, 2006.
DOI : 10.1001/jama.296.21.joc60162

R. Rolland, I. Brooksby, and E. Lenaghan, Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial, BMJ, vol.334, issue.7603, p.1098, 2007.
DOI : 10.1136/bmj.39164.568183.AE

R. Rolland, E. Lenaghan, and I. Harvey, Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial, BMJ, vol.330, issue.7486, p.293, 2005.
DOI : 10.1136/bmj.38338.674583.AE

R. Duncan and A. Zermansky, Study shows wrong people, wrong skills, wrong tools, BMJ, vol.334, p.1180, 2007.